Fact CheckerSign in

NCT06644911Recruiting

Obesity Doppler in Term Pregnancy

The Effect of Maternal Obesity on Umbilical and Uterine Artery Doppler in Term Pregnancy : a Cross-sectional Study

Source: ClinicalTrials.gov · Last updated 28 Jan 2025 · Not updated for over 12 months - ask the site whether it is still open

Brief summary (registry, in English)

Maternal obesity is an epidemic in the developed world like Egypt. There are many pregnancy-associated complications including pre-eclampsia, gestational diabetes, and increased rates of septic wound after cesarean delivery. As a potential explanation of the etiology of complications due to maternal obesity, the role of endothelial dysfunction in the systemic and peripheral vasculatures has been hypothesized. It has been proposed that some adverse pregnancy outcomes in obese patients may be mediated by placental insufficiency. Utero-placental insufficiency is typically associated with fetal growth restriction and low birth weight. Umbilical and uterine artery Doppler is widely accepted as a useful tool for monitoring high-risk pregnancies. Normally, uterine artery vascular impedance gradually decreases until the late mid-trimester, owing to the establishment of a low-resistance placental circulation. Obesity has little impact on uterine vascular changes reflected by the early uterine artery PI. However, in the second trimester, extreme obesity appears to impair the normal continued drop in uterine vascular resistance. Many studies have examined the relationship between BMI and Doppler changes in high-risk pregnancies, but few have addressed these changes in low-risk pregnancies.

Status (registry)
Recruiting
Study type
Observational
Enrollment
240 (estimated)
First submitted
15 Oct 2024
Start date
Jan 2025
Primary completion date
Jan 2026
Lead sponsor
Assiut University
Diseases
Obesity
NCT number
NCT06644911

What you commit to

  • Study type: Observational
  • Planned participants: 240
  • From Jan 2025 to the primary completion date, Jan 2026
  • 1 site in 1 country
  • Visits and tests: ask the trial team, the registry does not list them

Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.

Who cannot take part

Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.

Other illness

  • Women with antepartum hemorrhage.
  • Diabetes mellitus

Other

  • Placenta previa
  • Smokers and alcohol consumers
  • Preeclampsia
  • Women need urgent termination of pregnancy.

Who the study is looking for

  • Singleton pregnancy
  • Gestational age ≥ 37 weeks
  • Absence of fetal structural abnormalities
  • Absence of maternal comorbidities and/or complications.
  • Obese women (BMI ≥ 30 kg/m2) \[11\].
  • Normal weight (BMI 18.5-24.9) \[11\].

Age in the registry: 20 years to 35 years · Sex: Female · Accepts healthy volunteers

Full criteria on ClinicalTrials.gov

Sites (1)

Sites in registry order. Pick your city on the disease page to sort them by distance.

SiteCityCountrySite status
Woman's Health Hospital - Assiut university
Coordinator of this site? Confirm its status
AsyutEgyptRecruiting

This page is information, not medical advice. Discuss any trial with your doctor.